Impact of MRSA Decolonization Therapy on MRSA Infection and Transmission
Impact of MRSA Decolonization Therapy on MRSA Infection and Transmission
批准号:
8274320
负责人:
ARCH G MAINOUS
金额:
$49.97万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2013-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as one of the predominant pathogens associated with infections. MRSA infections have been associated with significant morbidity, mortality, and increased costs of care. Although colonization with MRSA is associated with a substantially increased risk for infection as well as transmission, decolonization of MRSA colonized hospital inpatients is not the standard of care. The standard strategy is to isolate the MRSA colonized patient and use contact precautions but not decolonize the patient. We know of no trials that have been conducted comparing the effectiveness of a standard isolation strategy with a decolonization strategy for both morbidity and transmission to household members post hospital discharge. We propose to compare the effectiveness of a standard patient isolation strategy without decolonization with a strategy of isolation and decolonization for hospital inpatients colonized with MRSA with respect to the following endpoints: A) reducing infection rates pre-discharge from the hospital among the index patients, B) reducing subsequent infections post-discharge among those without an infection in the index hospitalization, and C) reducing transmission of MRSA to household members post-discharge. This project is consistent with the informational goals of the Comparative Effectiveness portfolio at the Agency for Healthcare Research and Quality. We will conduct a randomized, double-blind, placebo-controlled trial among 918 adult (>20 years old) inpatients identified as colonized with MRSA through active surveillance at the Medical University of South Carolina Hospital. By using both randomization and a double-blind, placebo-control for mupirocin decolonization we are better assured that any differences between the two groups can be attributed to the addition of the active decolonization strategy. We will follow the index patients for 18 months post-discharge. In addition to assessing the development of infections pre and post-discharge from the hospital among the index patients and the transmission of MRSA from the index patients to their household members, we will also assess the development of mupirocin resistance that may result from the decolonization strategy. The implications of MRSA transmission and infection are substantial not only for morbidity and mortality in inpatient care but also for the community at large. A better understanding of the benefits and risks of MRSA decolonization in the hospital is essential to developing new methods for controlling the deleterious consequences of MRSA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of MRSA Decolonization Therapy on MRSA Infection and Transmission
-
批准号:8182361
-
项目类别:
-
资助金额:$49.68万
-
财政年份:2011
-
负责人:ARCH G MAINOUS
-
依托单位:
Hereditary Hemochromatosis and Telomere Length
-
批准号:8792891
-
项目类别:
-
资助金额:$3.68万
-
财政年份:2011
-
负责人:ARCH G MAINOUS
-
依托单位:
Hereditary Hemochromatosis and Telomere Length
-
批准号:8787357
-
项目类别:
-
资助金额:$3.06万
-
财政年份:2011
-
负责人:ARCH G MAINOUS
-
依托单位:
Hereditary Hemochromatosis and Telomere Length
-
批准号:8232605
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2011
-
负责人:ARCH G MAINOUS
-
依托单位:
Hereditary Hemochromatosis and Telomere Length
-
批准号:8508684
-
项目类别:
-
资助金额:$11.67万
-
财政年份:2011
-
负责人:ARCH G MAINOUS
-
依托单位:
ROLE OF TELOMERES WITH INSULIN RESISTANCE AND CORONARY DISEASE IN HEALTH CARE
-
批准号:7719610
-
项目类别:
-
资助金额:$8.6万
-
财政年份:2008
-
负责人:ARCH G MAINOUS
-
依托单位:
Racial Disparities in Diabetes in the US and the UK
-
批准号:6819074
-
项目类别:
-
资助金额:$14.6万
-
财政年份:2004
-
负责人:ARCH G MAINOUS
-
依托单位:
Racial Disparities in Diabetes in the US and the UK
-
批准号:6911658
-
项目类别:
-
资助金额:$14.6万
-
财政年份:2004
-
负责人:ARCH G MAINOUS
-
依托单位:
CORE--MEASUREMENT AND METHODS
-
批准号:6591870
-
项目类别:
-
资助金额:$5.31万
-
财政年份:2002
-
负责人:ARCH G MAINOUS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
去铁胺修饰Fe3+-鞣花酸纳米酶敷料靶向杀灭MRSA促进糖尿病伤口愈合机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢颖
-
依托单位:
野菊花内生真菌中抗MRSA活性成分及其作用机制
-
批准号:JCZRLH202601040
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
小分子化合物T-2307及其类似物通过PG-PMF-ATP通路抗MRSA感染的分子机制及应用研究
-
批准号:2026JJ30179
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:伍勇
-
依托单位:
靶向新航向:STAT3抑制剂对MRSA的抗菌作用及其分子机制研究
-
批准号:2026JJ50552
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴苑
-
依托单位:
基于天然产物吴茱萸次碱的抗MRSA先导发现、结构优化及机制研究
-
批准号:2026JJ50341
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨瑞阁
-
依托单位:
黎药红葱中靶向sarA蛋白抗MRSA生物被膜活性萘醌类成分及其作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈德力
-
依托单位:
基于中性粒细胞活化探讨食源性酿酒酵母葡聚糖SG90抗MRSA感染的免疫机制研究
-
批准号:JCZRLH202600868
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
新型抗MRSA先导化合物作用靶标PflB的确证及抗菌机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:程琦
-
依托单位:
基于基因组溯源方法体系阐明MRSA跨种
属传播机制和风险
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:叶小华
-
依托单位:
两株黄连内生真菌抗MRSA活性成分的发现及作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:尹国平
-
依托单位: